| Visiting Nurse Association Of Erie County | |
| 2253 West Grandview Boulevard, Erie, Pennsylvania 16506 | |
| (814) 454-2831 | |
| Name | Visiting Nurse Association Of Erie County |
|---|---|
| Location | 2253 West Grandview Boulevard, Erie, Pennsylvania |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 397034 |
| Ownership Type | Voluntary Non-profit - Other |
| Service Area Zip Codes | 16111, 16255, 16314, 16316, 16327, 16335, 16340, 16345, 16347, 16350, 16354, 16365, 16371, 16401, 16402, 16403, 16404, 16405, 16406, 16407, 16410, 16411, 16412, 16415, 16417, 16421, 16423, 16424, 16426, 16427, 16428, 16430, 16433, 16434, 16435, 16438, 16440, 16441, 16442, 16443, 16501, 16502, 16503, 16504, 16505, 16506, 16507, 16508, 16509, 16510, 16511, 16534, 16544, 16565 |
| NPI Number | 1932196136 |
| Organization Name | VISITING NURSE ASSOCIATION OF ERIE COUNTY |
| Doing Business As | VNA OF ERIE COUNTY |
| Address | 2253 W Grandview Blvd, Erie, PA 16506 |
| Phone Number | 814-454-2831 |
News Archive
An interesting letter in the New England Journal of Medicine on November 7, 2019, describes the successful outcome at one year of a rare genital transplant in a young war veteran who lost most of the lower part of the abdominal wall, the scrotum and both testes, and both legs below the knee, to a bomb blast.
Prof. Lars Leksell (1907-1986), inventor of the radiosurgical instrument that bears his name and a faculty member of Karolinska University Hospital (Solna, Sweden), performed the world's first Gamma Knife surgery at nearby Sophiahemmet Hospital, the location of the first Leksell Gamma Knife. Karolinska University Hospital recently acquired Elekta's fifth generation radiosurgery system, Leksell Gamma Knife Perfexion.
Researchers at RCSI have revealed that one quarter of suicide attempts are associated with dysfunction in how the brain interprets basic perceptual information, such as what we see, hear and think.
Dyax Corp. announced today that results from EDEMA3, the Company's first Phase 3 trial evaluating KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema, were published in the August issue of The New England Journal of Medicine. KALBITOR, discovered and developed by Dyax, is available in the United States for the treatment of acute attacks of HAE in patients 16 years of age and older.
A new formulation developed by University of South Australia scientists to treat antimicrobial-resistant bacterial infections in diabetic foot ulcers could also be used to kill the COVID-19 virus circulating in air conditioning systems.
› Verified 2 days ago
| Quality Rating: |
News Archive
An interesting letter in the New England Journal of Medicine on November 7, 2019, describes the successful outcome at one year of a rare genital transplant in a young war veteran who lost most of the lower part of the abdominal wall, the scrotum and both testes, and both legs below the knee, to a bomb blast.
Prof. Lars Leksell (1907-1986), inventor of the radiosurgical instrument that bears his name and a faculty member of Karolinska University Hospital (Solna, Sweden), performed the world's first Gamma Knife surgery at nearby Sophiahemmet Hospital, the location of the first Leksell Gamma Knife. Karolinska University Hospital recently acquired Elekta's fifth generation radiosurgery system, Leksell Gamma Knife Perfexion.
Researchers at RCSI have revealed that one quarter of suicide attempts are associated with dysfunction in how the brain interprets basic perceptual information, such as what we see, hear and think.
Dyax Corp. announced today that results from EDEMA3, the Company's first Phase 3 trial evaluating KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema, were published in the August issue of The New England Journal of Medicine. KALBITOR, discovered and developed by Dyax, is available in the United States for the treatment of acute attacks of HAE in patients 16 years of age and older.
A new formulation developed by University of South Australia scientists to treat antimicrobial-resistant bacterial infections in diabetic foot ulcers could also be used to kill the COVID-19 virus circulating in air conditioning systems.
› Verified 2 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 92.5 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 96.7 | 98.6 |
| How often the home health team checked patients’ risk of falling | 98.5 | 99.6 |
| How often the home health team checked patients for depression | 98.6 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 81.4 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 88.4 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 98.1 | 96.4 |
News Archive
An interesting letter in the New England Journal of Medicine on November 7, 2019, describes the successful outcome at one year of a rare genital transplant in a young war veteran who lost most of the lower part of the abdominal wall, the scrotum and both testes, and both legs below the knee, to a bomb blast.
Prof. Lars Leksell (1907-1986), inventor of the radiosurgical instrument that bears his name and a faculty member of Karolinska University Hospital (Solna, Sweden), performed the world's first Gamma Knife surgery at nearby Sophiahemmet Hospital, the location of the first Leksell Gamma Knife. Karolinska University Hospital recently acquired Elekta's fifth generation radiosurgery system, Leksell Gamma Knife Perfexion.
Researchers at RCSI have revealed that one quarter of suicide attempts are associated with dysfunction in how the brain interprets basic perceptual information, such as what we see, hear and think.
Dyax Corp. announced today that results from EDEMA3, the Company's first Phase 3 trial evaluating KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema, were published in the August issue of The New England Journal of Medicine. KALBITOR, discovered and developed by Dyax, is available in the United States for the treatment of acute attacks of HAE in patients 16 years of age and older.
A new formulation developed by University of South Australia scientists to treat antimicrobial-resistant bacterial infections in diabetic foot ulcers could also be used to kill the COVID-19 virus circulating in air conditioning systems.
› Verified 2 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 68.2 | 79.6 |
| How often patients got better at getting in and out of bed | 65.2 | 81.1 |
| How often patients got better at bathing | 68.4 | 82.3 |
| How often patients’ breathing improved | 66.1 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 90.3 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 60.6 | 75 |
| How often home health patients had to be admitted to the hospital | 15.5 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 15 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 89.1 | 94 |
News Archive
An interesting letter in the New England Journal of Medicine on November 7, 2019, describes the successful outcome at one year of a rare genital transplant in a young war veteran who lost most of the lower part of the abdominal wall, the scrotum and both testes, and both legs below the knee, to a bomb blast.
Prof. Lars Leksell (1907-1986), inventor of the radiosurgical instrument that bears his name and a faculty member of Karolinska University Hospital (Solna, Sweden), performed the world's first Gamma Knife surgery at nearby Sophiahemmet Hospital, the location of the first Leksell Gamma Knife. Karolinska University Hospital recently acquired Elekta's fifth generation radiosurgery system, Leksell Gamma Knife Perfexion.
Researchers at RCSI have revealed that one quarter of suicide attempts are associated with dysfunction in how the brain interprets basic perceptual information, such as what we see, hear and think.
Dyax Corp. announced today that results from EDEMA3, the Company's first Phase 3 trial evaluating KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema, were published in the August issue of The New England Journal of Medicine. KALBITOR, discovered and developed by Dyax, is available in the United States for the treatment of acute attacks of HAE in patients 16 years of age and older.
A new formulation developed by University of South Australia scientists to treat antimicrobial-resistant bacterial infections in diabetic foot ulcers could also be used to kill the COVID-19 virus circulating in air conditioning systems.
› Verified 2 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
An interesting letter in the New England Journal of Medicine on November 7, 2019, describes the successful outcome at one year of a rare genital transplant in a young war veteran who lost most of the lower part of the abdominal wall, the scrotum and both testes, and both legs below the knee, to a bomb blast.
Prof. Lars Leksell (1907-1986), inventor of the radiosurgical instrument that bears his name and a faculty member of Karolinska University Hospital (Solna, Sweden), performed the world's first Gamma Knife surgery at nearby Sophiahemmet Hospital, the location of the first Leksell Gamma Knife. Karolinska University Hospital recently acquired Elekta's fifth generation radiosurgery system, Leksell Gamma Knife Perfexion.
Researchers at RCSI have revealed that one quarter of suicide attempts are associated with dysfunction in how the brain interprets basic perceptual information, such as what we see, hear and think.
Dyax Corp. announced today that results from EDEMA3, the Company's first Phase 3 trial evaluating KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema, were published in the August issue of The New England Journal of Medicine. KALBITOR, discovered and developed by Dyax, is available in the United States for the treatment of acute attacks of HAE in patients 16 years of age and older.
A new formulation developed by University of South Australia scientists to treat antimicrobial-resistant bacterial infections in diabetic foot ulcers could also be used to kill the COVID-19 virus circulating in air conditioning systems.
› Verified 2 days ago
The patient survey data of Visiting Nurse Association Of Erie County is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 85 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 82 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 75 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 82 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 71 | 78 |
News Archive
An interesting letter in the New England Journal of Medicine on November 7, 2019, describes the successful outcome at one year of a rare genital transplant in a young war veteran who lost most of the lower part of the abdominal wall, the scrotum and both testes, and both legs below the knee, to a bomb blast.
Prof. Lars Leksell (1907-1986), inventor of the radiosurgical instrument that bears his name and a faculty member of Karolinska University Hospital (Solna, Sweden), performed the world's first Gamma Knife surgery at nearby Sophiahemmet Hospital, the location of the first Leksell Gamma Knife. Karolinska University Hospital recently acquired Elekta's fifth generation radiosurgery system, Leksell Gamma Knife Perfexion.
Researchers at RCSI have revealed that one quarter of suicide attempts are associated with dysfunction in how the brain interprets basic perceptual information, such as what we see, hear and think.
Dyax Corp. announced today that results from EDEMA3, the Company's first Phase 3 trial evaluating KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema, were published in the August issue of The New England Journal of Medicine. KALBITOR, discovered and developed by Dyax, is available in the United States for the treatment of acute attacks of HAE in patients 16 years of age and older.
A new formulation developed by University of South Australia scientists to treat antimicrobial-resistant bacterial infections in diabetic foot ulcers could also be used to kill the COVID-19 virus circulating in air conditioning systems.
› Verified 2 days ago
Visiting Nurse Association Of Erie County Location: 2253 West Grandview Boulevard, Erie, Pennsylvania 16506 Ratings: Phone: (814) 454-2831 | |
Upmc Home Healthcare Location: 1700 Peach Street, Suite 244, Erie, Pennsylvania 16501 Ratings: Phone: (814) 877-6120 | |
Aveanna Healthcare Location: 240 W 11th Street, Erie, Pennsylvania 16501 Ratings: NA Phone: (814) 459-4849 | |
Interim Healthcare Of Erie Location: 2206 W 15th Street, Erie, Pennsylvania 16505 Ratings: Phone: (814) 836-8836 | |
Caregivers Health Services Location: 2820 W 3rd St Ste 8 Ebco Park, Erie, Pennsylvania 16505 Ratings: Phone: (814) 838-8696 | |
Bayada Home Health Care, Inc. Location: 1600 Penninsula Drive, Suite 17, Erie, Pennsylvania 16505 Ratings: NA Phone: (814) 835-2400 |